- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | H.C. Wainwright reiterates Buy on Alpha Tau stock, $15 target | 1 | Investing.com | ||
| ALPHA TAU MEDICAL Aktie jetzt für 0€ handeln | |||||
| Di | Piper Sandler hebt Kursziel für Alpha Tau Medical nach Meilensteinen an | 2 | Investing.com Deutsch | ||
| Di | Piper Sandler raises Alpha Tau Medical stock price target on milestones | 1 | Investing.com | ||
| Mo | Alpha Tau Medical GAAP EPS of -$0.26 | 3 | Seeking Alpha | ||
| Mo | Alpha Tau Medical Ltd.: Alpha Tau Announces First Quarter 2026 Financial Results and Provides Corporate Update | 1.427 | GlobeNewswire (Europe) | - Groundbreaking interim results from U.S. REGAIN trial in recurrent glioblastoma demonstrate 100% local disease control, 67% complete response rate, and favorable safety profile - - Completion of... ► Artikel lesen | |
| Mo | Alpha Tau Medical Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 12.05. | H.C. Wainwright raises Alpha Tau Medical stock price target to $15 on trial data | 3 | Investing.com | ||
| 12.05. | H.C. Wainwright hebt Kursziel für Alpha Tau Medical nach Studiendaten auf 15 US-Dollar an | 1 | Investing.com Deutsch | ||
| 11.05. | Alpha Tau Medical Stock Surges As Interim Brain Tumor Trial Data Sparks Rally | 1 | Benzinga.com | ||
| 11.05. | Studienerfolg bei Hirntumoren: Aktie von Alpha Tau Medical legt kräftig zu | 2 | Investing.com Deutsch | ||
| 11.05. | Alpha Tau Medical Ltd. - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 08.05. | Alpha Tau: Patientenrekrutierung für zulassungsrelevante Hautkrebs-Studie abgeschlossen | 2 | Investing.com Deutsch | ||
| 08.05. | Alpha Tau completes enrollment in U.S. skin cancer pivotal trial | 1 | Investing.com | ||
| 08.05. | Alpha Tau Medical Ltd.: Alpha Tau Completes Patient Enrollment in its U.S. Pivotal Skin Cancer Study, Advancing Towards Goal of FDA Approval of Alpha DaRT to Treat Recurrent Cutaneous Squamous Cell Carcinoma | 456 | GlobeNewswire (Europe) | - First U.S. pivotal study for Alpha Tau to have completed enrollment, representing a critical milestone on the path towards potential FDA pre-market approval (PMA); Company has already initiated... ► Artikel lesen | |
| 07.05. | Alpha Tau Medical Ltd.: Alpha Tau Successfully Treats First Pancreatic Cancer Patient in Italy with Alpha DaRT at the University of Verona's Pancreas Institute | 2 | GlobeNewswire (USA) | ||
| 04.05. | Alpha Tau reports disease control in pancreatic cancer trial | 3 | Investing.com | ||
| 04.05. | Alpha Tau Medical Ltd.: Alpha Tau Announces 100% Local Disease Control Rate and Favorable Safety Profile Observed in Alpha DaRT Pancreatic Cancer Trials Presented at DDW 2026 | 1 | GlobeNewswire (USA) | ||
| 04.05. | Alpha Tau Medical Ltd. - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 27.04. | Alpha Tau: Abstract zu Bauchspeicheldrüsenkrebs für ASCO-Jahrestagung angenommen | 2 | Investing.com Deutsch | ||
| 27.04. | Alpha Tau abstract accepted at ASCO annual meeting in May | 2 | Investing.com |
1 2 3 Weiter >>
55 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PLUS THERAPEUTICS | 4,925 | +0,20 % | Plus Therapeutics Inc.: Plus Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update on REYOBIQ Clinical Program and CNSide Commercial Rollout | HOUSTON, May 15, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) ("Plus" or the "Company"), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals... ► Artikel lesen | |
| ORGANON | 11,550 | -0,17 % | Organon & Co.: Organon präsentiert auf der ISPOR 2026 neue Forschungsergebnisse rund um Zugang und Nutzen | Die neuen Studienergebnisse werden die Erschwinglichkeit von Verhütungsmitteln, die Verbreitung von Biosimilars sowie auf den Zugang ausgerichtete Analysen im gesamten Portfolio der Frauengesundheit... ► Artikel lesen | |
| CO-DIAGNOSTICS | 2,380 | -0,42 % | Co-Diagnostics Reports First Quarter 2026 Financial Results | Advancing Global Commercialization Through CoSara Regulatory Progress and Regional Expansion
Executing Clinical Strategy with Upper Respiratory Submission Preparation... ► Artikel lesen | |
| SENSEONICS | 4,720 | -4,06 % | Senseonics Holdings, Inc. - S-8, Securities to be offered to employees in employee benefit plans | ||
| VIRIDIAN THERAPEUTICS | 14,700 | -3,29 % | XFRA 1S1: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| INSPIRE MEDICAL SYSTEMS | 37,000 | -2,63 % | Inspire Medical Systems, Inc. Announces First Quarter 2026 Financial Results and Updates 2026 Guidance | First quarter revenue growth of 1.6%First quarter diluted EPS of $(0.39); adjusted diluted EPS of $0.10First quarter operating cash flow of $12.8 million MINNEAPOLIS, May 04, 2026 (GLOBE NEWSWIRE)... ► Artikel lesen | |
| VYOME | 2,140 | +1,42 % | Vyome: Positive Phase-2-Daten für Wundbehandlung bei Krebspatienten | ||
| EMBECTA | 2,620 | -0,27 % | Embecta Corp.: embecta Completes Acquisition of Owen Mumford Holdings Limited | PARSIPPANY, N.J., May 15, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (Nasdaq: EMBC), a global leader in diabetes care technology, today announced that it has completed its previously announced... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 28,090 | -0,07 % | PROCEPT BioRobotics Reports First Quarter 2026 Financial Results | SAN JOSE, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| AXOGEN | 37,590 | +2,40 % | Axogen, Inc.: Axogen Announces Pricing of Upsized $124 Million Public Offering of Common Stock | ALACHUA, Fla. and TAMPA, Fla., Jan. 21, 2026 (GLOBE NEWSWIRE) -- Axogen, Inc. (Nasdaq: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral... ► Artikel lesen | |
| TACTILE SYSTEMS TECHNOLOGY | 20,180 | -5,61 % | Tactile Systems Technology, Inc.: Tactile Medical Acquires LymphaTech, Expanding Breadth and Depth of its Lymphedema Solutions Portfolio | MINNEAPOLIS, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. ("Tactile Medical"; the "Company") (Nasdaq: TCMD), a medical technology company providing therapies for people with... ► Artikel lesen | |
| APYX MEDICAL | 3,320 | +1,84 % | Apyx Medical study shows improved satisfaction with Renuvion | ||
| GLAUKOS | 121,00 | -2,42 % | Glaukos - GKOS: Pullback-Setup mit Unterstützung bei 130 USD! | Starkes Wachstum erwartet! Aber Achtung: Insider verkaufen Glaukos-Aktien (GKOS) im Wert von 4.2 Millionen USD! Glaukos (GKOS) - US3773221029 Rückblick: Aufgrund der stark überkauften Situation am US-Gesamtmarkt... ► Artikel lesen | |
| LEXARIA BIOSCIENCE | 0,581 | -0,09 % | Lexaria Bioscience Corp.: Lexaria Receives Independent Review Board Approval to Begin Human Pilot Study #7 | KELOWNA, BC / ACCESS Newswire / May 19, 2026 / Lexaria Bioscience Corp. (NASDAQ:LEXX) ("Lexaria" or the "Company"), a global innovator in oral drug delivery platforms, is pleased to announce that ethics... ► Artikel lesen | |
| ITONIC | 0,288 | 0,00 % | iTonic Holdings Ltd Granted An Extension of Additional 180-Day by Nasdaq to Regain Compliance with Minimum Bid Price Rule | BEIJING, China, April 23, 2026 (GLOBE NEWSWIRE) -- iTonic Holdings Ltd (the "Company" or "ITOC"), a healthcare solution provider specializing in treatment planning systems for brachytherapy and other... ► Artikel lesen |
Das Unternehmen ALPHA TAU MEDICAL LTD kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 11,180 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ALPHA TAU MEDICAL LTD finden Sie auf Wallstreet Online.